Total Payments
$3,213
2024 Payments
$2,083
Companies
47
Transactions
144
Medicare Patients
157
Medicare Billing
$14,164
Payment Breakdown by Category
Food & Beverage$3,193 (99.4%)
Education$20.00 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,193 | 143 | 99.4% |
| Education | $20.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $370.04 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $260.60 | 14 | $0 (2024) |
| PFIZER INC. | $190.73 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $177.74 | 5 | $0 (2024) |
| Tactile Systems Technology Inc | $163.27 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $146.43 | 8 | $0 (2024) |
| Daiichi Sankyo Inc. | $124.94 | 6 | $0 (2024) |
| Adaptive Biotechnologies Corporation | $107.44 | 5 | $0 (2024) |
| Incyte Corporation | $103.93 | 5 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $103.37 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,083 | 91 | AstraZeneca Pharmaceuticals LP ($250.21) |
| 2023 | $689.76 | 28 | Janssen Biotech, Inc. ($131.21) |
| 2022 | $16.27 | 1 | Tactile Systems Technology Inc ($16.27) |
| 2021 | $424.20 | 24 | Esperion Therapeutics, Inc. ($81.12) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Helsinn Therapeutics (U.S.), Inc. | AKYNZEO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Menarini Silicon Biosystems, Inc. | Cellsearch (Device) | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: Diagnostics | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: ONCOLOGY | ||||||
| 12/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Oncology | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.55 | General |
| 11/19/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $17.71 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Oncology | ||||||
| 10/31/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/30/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $22.42 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $22.66 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Rare Disease | ||||||
| 10/21/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/16/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $24.19 | General |
| Category: Hematology/Oncology | ||||||
| 10/02/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 58 | 59 | $17,032 | $3,519 |
| 2022 | 5 | 88 | 103 | $50,178 | $9,949 |
| 2021 | 1 | 11 | 11 | $1,793 | $696.08 |
Total Patients
157
Total Services
173
Medicare Billing
$14,164
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 42 | $10,776 | $2,110 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 17 | $6,256 | $1,409 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 45 | $19,499 | $3,943 | 20.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 16 | 19 | $11,762 | $2,150 | 18.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $7,319 | $1,617 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $7,118 | $1,360 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $4,480 | $879.07 | 19.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $1,793 | $696.08 | 38.8% |
About Ancy Thomas, NP
Ancy Thomas, NP is a Family healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/22/2018. The National Provider Identifier (NPI) number assigned to this provider is 1952877409.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ancy Thomas, NP has received a total of $3,213 in payments from pharmaceutical and medical device companies, with $2,083 received in 2024. These payments were reported across 144 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($3,193).
As a Medicare-enrolled provider, Thomas has provided services to 157 Medicare beneficiaries, totaling 173 services with total Medicare billing of $14,164. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Plano, TX
- Active Since 10/22/2018
- Last Updated 10/11/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1952877409
Products in Payments
- KEYTRUDA (Biological) $246.08
- Flexitouch Plus (Device) $143.27
- DARZALEX (Biological) $131.21
- ENHERTU (Biological) $123.70
- IMFINZI (Biological) $114.66
- clonoSEQ (Device) $107.44
- ZEPZELCA (Drug) $103.37
- OPTIMIZER (Device) $100.47
- IBRANCE (Drug) $94.70
- AYVAKIT (Drug) $81.95
- NEXLETOL (Drug) $81.12
- Livalo (Drug) $80.55
- Enhertu (Drug) $78.23
- MONJUVI (Drug) $77.84
- Lenvima (Drug) $64.64
- JARDIANCE (Drug) $62.70
- LIBTAYO (Biological) $61.11
- CALQUENCE (Drug) $55.27
- OPDIVO (Biological) $54.03
- ICLUSIG (Drug) $50.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Plano
Kori Nelson, Fnp-C, FNP-C
Family — Payments: $107,146
Family $107,146
Abiola Amure, Fnp-C, FNP-C
Family — Payments: $14,511
Family $14,511
Vicki Redpath
Family — Payments: $10,534
Family $10,534
Katelynn Mann, Msn, Fnp, MSN, FNP
Family — Payments: $10,231
Family $10,231
Blen Daniel, Fnp, FNP
Family — Payments: $9,096
Family $9,096
Ronnie Terry, Aprn, Rnfa, APRN, RNFA
Family — Payments: $8,895
Family $8,895